HIGH TECH MEDS: For Novartis, the tie-up is a long-term bet on a technology that might just transform medicine delivery several years down the road.
LONDON: Swiss drugmaker Novartis is raising its bet on smart technology by collaborating with US startup Rani Therapeutics on a “robotic pill” for complex biotech drugs that would normally have to be given by injection.
Rani said it would run feasibility studies over the next 18-24 months to evaluate how selected Novartis biologic medicines can be delivered into the bloodstream using its unique device.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
